Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant

Bone Marrow Transplant. 2022 Jun;57(6):1031-1033. doi: 10.1038/s41409-022-01677-8. Epub 2022 Apr 15.

Authors

Affiliations

¹ Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
² Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
³ Blood and Marrow Transplantation, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
⁴ Blood and Marrow Transplantation, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. hamiltb2@ccf.org.

PMID: 35428866
DOI: 10.1038/s41409-022-01677-8

No abstract available

Publication types

Letter

MeSH terms

Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Retrospective Studies
Risk Assessment
Transplantation, Homologous